- Connect
- About
- Education
- Publications
Hilary L. Surratt, PhD, is an Associate Professor in the Center for Health Services Research and the Department of Internal Medicine at the University of Kentucky. Before coming to CHSR, she was Professor and Co-Director of the Center for Applied Research on Substance Use and Health Disparities at Nova Southeastern University in Fort Lauderdale, Florida. She also maintains an affiliation as a Guest Professor in the Department of Psychiatry at the Federal University of Rio Grande do Sul in Porto Alegre, Brazil.
Dr. Surratt has expertise in the areas of illicit and prescription drug abuse, prescription drug diversion, and drug-related HIV infection. Her work has included the development and evaluation of behavioral HIV and HCV interventions for vulnerable substance abusing populations, as well as epidemiologic studies of prescription drug diversion, including opioid analgesics and antiretroviral medications. She has served as PI or Co-Investigator on more than 10 NIH-funded studies, and has substantial experience with cross-cultural research, having previously served as a senior investigator on several HIV prevention/intervention initiatives in Brazil and the U.S. Virgin Islands. Her current research focuses on the examination of syringe exchange programs in Kentucky and the development of targeted interventions to link prescription opioid injectors to substance abuse treatment.
Dr. Surratt has published widely in both English and foreign-language journals in the areas of substance abuse, drug diversion, HIV/AIDS, violence, and drug policy. She has authored or co-authored more than 100 peer-reviewed scientific articles, and is an active participant in professional meetings, both in the United States and internationally. She obtained her BS in Psychology from the University of Florida, an MA in Sociology/Latin American Studies from the University of Florida, and a Doctorate in Psychology from the Graduate School & University Center, City University of New York.
Research Interests: Substance abuse and health disparities research; Evidence-based intervention and policy approaches to reduce the health harms of opioid abuse, Social determinants of health; neighborhood, community-level characteristics that affect patterns of substance abuse, HIV risk/resiliency, behavior change; Structural drivers of health behaviors and outcome; HIV-related stigma; health service access; Translation of evidence-based research findings into applied practice and policy; Participatory research methods; mixed methods research approaches
Current Research Projects: Tracking and Evaluation Core of UK’s Center for Clinical and Translational Science; Kentucky Consortium for Accountable Health Communities; Examining Social Influences on Syringe Exchange Uptake Among Rural PWID at Risk for HIV; Project MISSION (Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptimalCare through engagement)
A1. Articles in Web of Science
1. Levi-Minzi, Maria A., Surratt, Hilary L., O'Grady, Catherine E., Kurtz, Steven P. In press. “Finding What Works: Predicting Health or Social Service Linkage in Drug Using, African American Female Sex Workers in Miami, FL,” Health Care for Women International.
Impact Factor 2014: 0.802, Q4 in Public, Environmental & Occupational Health; Q2 in Women’s Studies
2. Dart, Richard C., Surratt, Hilary L., Le Lait, Marie-Claire, Stivers, Yamilka, Bebarta, Vikhyat S., Freifeld, Clark C., Brownstein, John S., Burke, John J., Kurtz, Steven P., and Dasgupta, Nabarun. In press. “Diversion and Illicit Sale of Extended Release Tapentadol in the United States,” Pain Medicine.
Impact Factor 2013: 2.24, Q2 in Medicine, General & Internal
3. Surratt, Hilary L., Kurtz, Steven P., Levi-Minzi, Maria A., and Chen, Minxing. 2015. “Environmental Influences on HIV Medication Adherence: The Role of Neighborhood Disorder,” American Journal of Public Health, 105(8), 1660-1666.
Impact factor 2013: 4.22; Q1 in Public, Environmental & Occupational Health
4. Dart, Richard C., Surratt, Hilary L., Cicero, Theodore J., Parrino, Mark W., Severtson, S. Geoff, Bucher-Bartelson, Becki, and Green, Jody L. 2015. “Trends in Opioid Analgesic Abuse and Mortality in the United States,” New England Journal of Medicine, 372:241-8.
Impact Factor 2013: 54.4, Q1 in Medicine, General & Internal
5. Tsuyuki, Kiyomi, and Surratt, Hilary L. 2015. “Antiretroviral Drug Diversion Links Social Vulnerability to Poor Medication Adherence in Substance Abusing Populations,” AIDS & Behavior, 19(5): 869-881.
Impact Factor 2013: 3.31, Q1 in Social Sciences, Biomedical
6. Surratt, H.L., O’Grady, C.L., Levi-Minzi, M.A., Kurtz, S.P. 2015. “Medication Adherence Challenges among HIV Positive Substance Abusers: The Role of Food and Housing Insecurity,” AIDS Care, 27(3), 307-314.
Impact Factor 2013: 2.19, Q1 in Social Sciences, Biomedical
7. Tsuyuki, K., Surratt, H.L., Levi-Minzi, M.A., O’Grady, C. L., Kurtz, S.K. 2015. “The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV disease management among vulnerable populations.” AIDS and Behavior, 19(5), 857-868.
Impact Factor 2013: 3.31, Q1 in Social Sciences, Biomedical
8. Surratt, H.L., Kurtz, S.P., Levi-Minzi, M.A., Cicero, T.J., Tsuyuki, K., O’Grady, C.L. 2015. “Pain Treatment and Antiretroviral Medication Adherence among Vulnerable HIV-positive Patients,” AIDS Patient Care and STDs, 29(4), 186-192.
Impact Factor 2013: 3.57, Q1 in Public, Environmental & Occupational Health
9. Remy, Lysa, Lisia Von Diemen, Hilary L. Surratt, Steven P. Kurtz, and Flavio Pechansky. 2014. “Changes in method for obtaining better outcomes in the recruitment of synthetic drug users,” Addiction Research & Theory, 22(5):380-385.
Impact Factor 2014: 1.430, Q1 in Social Issues; Q3 in Substance Abuse
10. Cicero, TJ, Ellis, MS, Surratt, HL, & Kurtz, SP. 2014. “Factors contributing to the rise of buprenorphine misuse: 2008-2013,” Drug and Alcohol Dependence, 142:98-104.
Impact factor 2013: 3.27, Q1 in Substance Abuse
11. Varga, LM, & Surratt, HL. 2014. “Predicting Health Care Utilization in Marginalized Populations: Black, Female, Street-based Sex Workers,” Women's Health Issues, 24(3):e335-343.
Impact factor 2012: 1.63, Q1 in Women’s Studies
12. Davis, GP, Surratt, HL, Levin, FR, & Blanco, C. 2013. “Antiretroviral Medication: An Emerging Category of Prescription Drug Misuse,” The American Journal on Addictions.
Impact Factor 2013: 1.74, Q1 in Medicine
13. Levi-Minzi, Maria A., & Hilary L. Surratt. 2014. “HIV stigma among substance abusing people living with HIV/AIDS: Implications for HIV treatment,” AIDS Patient Care and STDs, 28(8): 442-451.
Impact Factor 2013: 3.58, Q1 in Public, Environmental & Occupational Health
14. Surratt, H.L., O’Grady, C.L., Kurtz, S.P., Buttram, M.E., & Levi-Minzi, M.A. 2014. “HIV Testing and Engagement in Care among Highly Vulnerable Female Sex Workers: Implications for Treatment as Prevention Models,” Journal of Health Care for the Poor and Underserved, 25(3):1360-1378.
Impact Factor 2013: 0.90, Q4 in Public, Environmental & Occupational Health
15. Cicero, T.J., Ellis, M.S., Surratt, H.L., & Kurtz, S.P. 2014. “The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years,” JAMA Psychiatry 71(7): 821-826.
Impact Factor 2015: 12.0, Q1 in Psychiatry
16. Surratt, H.L., O’Grady, C.L., Kurtz, S.P., Levi-Minzi, M.A., & Chen, M. 2014. “Outcomes of a Behavioral Intervention to Reduce HIV Risk among Drug-involved Female Sex Workers,” AIDS & Behavior, 18(4):726-39.
Impact Factor 2013: 3.31, Q1 in Social Sciences, Biomedical
17. Lavonas EJ, Severtson SG, Martinez EM, Bucher-Bartelson B, Le Lait M-C, Green JL, Murrelle L, Cicero TJ, Kurtz SP, Rosenblum A, Surratt HL, Dart RC. 2014. “Abuse and diversion of buprenorphine sublingual tablets and film,” Journal of Substance Abuse Treatment, 47(1): 27–34.
Impact Factor 2013: 1.86, Q2 in Substance Abuse
18. Surratt, HL, O’Grady, CL, Kurtz, SP, Stivers, Y, Cicero, TJ, Dart, RC, & Chen, M. 2014. “Reductions in Prescription Opioid Diversion following Recent Legislative Interventions in Florida,” Pharmacoepidemiology and Drug Safety, 23(3): 314-320. Impact Factor 2013: 3.17, Q2 in Pharmacology & Pharmacy
19. O’Grady, CL, Surratt, HL, Kurtz, SP, & Levi-Minzi, MA. 2014. "Nonmedical prescription drug users in private vs. public substance abuse treatment: A cross sectional comparison of demographic and HIV risk behavior profiles." Substance Abuse Treatment, Prevention, and Policy, 9(9).
Impact Factor 2013: 1.45, Q3 in Substance Abuse
20. Kurtz, SP, Buttram, ME, & Surratt, HL. 2014. “Vulnerable Infected Populations and Street Markets for ARVs: Potential Implications for PrEP Rollout in the US.” AIDS Care, 26(4): 411-415.
Impact Factor 2013: 2.19 Q1 in Social Sciences, Biomedical
21. Minieri, A., Staton-Tindall, M., Leukefeld, C., Clarke, J., Surratt, H., Frisman, L. 2014. “Relationship power as a mediator of intimate partner violence and mental health issues among incarcerated, substance-using women,” International Journal of Offender Therapy and Comparative Criminology, 58(3): 303-319.
Impact Factor 2013: 1.08, Q2 in Criminology & Penology
22. Buttram, ME, Kurtz, SP, Surratt, HL, and Levi-Minzi, MA. 2014. “Health and Social Problems Associated With Prescription Opioid Misuse Among a Diverse Sample of Substance-Using MSM,” Substance Use and Misuse, 49(3): 277-284.
Impact Factor 2013: 1.22, Q3 in Substance Abuse
23. Buttram, ME., Surratt, HL, & Kurtz, SP. 2014. “Resilience and Syndemic Risk Factors among African American Female Sex Workers.” Psychology, Health & Medicine, 19(4):442-452.
Impact factor 2013: 1.53; Q2 in Public, Environmental & Occupational Health
24. Cicero, TJ, Ellis, MS, Surratt, HL, & Kurtz, SP. 2013. “Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States,” Pain, 154(12): 2639-2648.
Impact Factor 2013: 5.83, Q1 in Neurosciences
25. Levi-Minzi, MA, Surratt, HL, Kurtz, SP, & Buttram, ME. 2013. “The Under-treatment of Pain: A Prescription for Opioid Misuse among the Elderly.” Pain Medicine, 14(11), 1719-1729.
Impact Factor 2013: 2.24, Q2 in Medicine, General & Internal
26. Severtson, SG, Bucher Bartelson, B., Davis, JM, Muñoz, A., Schneider, MF, Chilcoat, H, Coplan, PM, Surratt, HL, & Dart, RC. 2013. “Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010." The Journal of Pain, 14(10):1122-1130. Impact factor 2013: 4.21; Q1 in Neurosciences
27. Surratt, HL, Kurtz, SP, Cicero, TJ, O’Grady, CL, & Levi-Minzi, MA. 2013. “Antiretroviral Medication Diversion among HIV-positive Substance Abusers in South Florida.” American Journal of Public Health, 103(6):1026-1027
Impact factor 2013: 4.22; Q1 in Public, Environmental & Occupational Health
28. Kurtz, SP., Stall, RD, Buttram, ME, Surratt, HL, & Chen, M. 2013. “A randomized trial of a behavioral intervention for high risk substance-using MSM.” AIDS and Behavior, 17(9):2914-2926.
Impact factor 2013: 3.31; Q1 in Social Sciences, Biomedical
29. Dasgupta, N, Freifeld, C, Brownstein, J, Menone, C, Surratt, H, Poppish, L, Green, J, Lavonas, E, & Dart, R. 2013. “Crowdsourcing Black Market Prices for Prescription Opioids,” Journal of Medical Internet Research, 15(8): UNSP e178.
Impact factor 2013: 4.66; Q1 in HealthCare Sciences & Services
30. Kurtz, SP, Surratt, HL, Buttram, ME, Levi-Minzi, MA, & Chen, M. 2013. “Interview as intervention: The case of young adult multidrug users in the club scene.” Journal of Substance Abuse Treatment, 44(3):301-308.
Impact Factor 2013: 1.86, Q2 in Substance Abuse
31. Remy, L, Narvaez, J, Sordi, A, Guimaraes, LS, Von Diemen, L, Surratt, HL, Kurtz, SP, & Pechansky F. 2013. “Correlates of unprotected sex in a sample of young club drug users.” Clinics, 68(11):1384-1391.
Impact Factor 2013: 1.42, Q2 in Medicine, General & Internal
32. Buttram, ME, Kurtz, SP, & Surratt, HL. 2013. “Substance Use and Sexual Risk Mediated by Social Support among Black Men.” Journal of Community Health, 38(1):62-69.
Impact factor 2012: 1.57, Q2 in Public, Environmental & Occupational Health
33. Cicero, TJ, Ellis, MS, & Surratt, HL. 2012. “Effect of Abuse-Deterrent Formulation of OxyContin,” New England Journal of Medicine, 367(2):187-189.
Impact Factor 2012: 54.4, Q1 in HealthCare Sciences & Services
34. Surratt, HL, & Kurtz, SP. 2012. “Foster Care History and HIV Infection among Drug-Using African American Female Sex workers.” AIDS and Behavior, 16(4):982-989.
Impact factor 2012: 2.91, Q1 in Social Sciences, Biomedical
35. Kurtz, SP, Buttram, ME, Surratt, HL & Stall, RD. 2012. “Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance using MSM.” AIDS Education and Prevention 24(3):193-205.
Impact factor 2012: 1.50, Q1 in Education & Educational Research
36. Rigg, KK, Kurtz, SP, & Surratt, HL. 2012. “Patterns of Prescription Medication Diversion among Drug Dealers.” Drugs: Education, Prevention and Policy, 19(2):145-155.
Impact factor 2012: 0.59, Q4 in Substance Abuse
37. Surratt, HL, Kurtz, SP, Chen, M. & Mooss, A. 2012. “HIV risk among female sex workers in Miami: The impact of violent victimization and untreated mental illness.” AIDS Care, 24(5):553-561.
Impact factor 2012: 1.83, Q1 in Social Sciences, Biomedical
38. Cicero, TJ, Surratt, HL, Kurtz, SP, Ellis, MS, & Inciardi, JA. 2012. “Patterns of prescription opioid abuse and co-morbidity in an aging treatment population.” Journal of Substance Abuse Treatment, 42(1):87-94.
Impact factor 2012: 1.98, Q2 in Substance Abuse
39. Surratt, HL, Kurtz, SP, & Cicero, TJ. 2011. “Alternative Routes of Administration and Risk for HIV among Prescription Opioid Abusers.” Journal of Addictive Diseases, 30(4):334-41.
Impact factor 2011: 1.46, Q2 in Substance Abuse
40. Kurtz, SP., Surratt, HL, Levi-Minzi, MA, & Mooss, A. 2011. “Benzodiazepine dependence among multidrug users in the club scene.” Drug and Alcohol Dependence, 119(1-2):99-105.
Impact factor 2011: 3.38, Q1 in Substance Abuse
41. Pechansky, F, Remy, L, Surratt, HL, Kurtz, SP, Rocha, T, Von Diemen, L, Benzano Bumaguin, D, & Inciardi, JA. 2011. “Age of sexual initiation, psychiatric symptoms, and sexual risk behavior among ecstasy and LSD users in Porto Alegre, Brazil: A preliminary analysis,” Journal of Drug Issues 41(2):217-232.
Impact factor 2011: 0.38, Q4 in Substance Abuse
42. Cicero, TJ, Kurtz, SP, Surratt, HL, Ibanez, GE, Ellis, MS, Levi-Minzi, MA, & Inciardi, JA. 2011. “Multiple determinants of specific modes of prescription opioid diversion.” Journal of Drug Issues 41(2):283-304.
Impact factor 2011: 0.38, Q4 in Substance Abuse
43. Staton-Tindall, M, Frisman, L, Lin, H, Leukefeld, C, Oser, C, Havens, J, Prendergast, M, Surratt, HL & Clarke, J. 2011. “Relationship influence and health risk behavior among re-entering women offenders,” Women’s Health Issues, 21(3):230-238.
Impact factor 2012: 1.63, Q1 in Women’s Studies
44. Inciardi, JA, Surratt, HL, Cicero, TJ, Rosenblum, A, Ahwah, C, Bailey, JE, Dart, RC, & Burke, JJ. 2010. “Prescription Drugs Purchased Through the Internet: Who are the End Users?,” Drug and Alcohol Dependence, 110(1-2):21-29.
Impact factor 2010: 3.36, Q1 in Substance Abuse
45. Ibañez, GE, Kurtz, SP, Surratt, HL, & Inciardi, JA. 2010. “Correlates of Heterosexual Anal Intercourse Among Substance-Using Club-Goers,” Archives of Sexual Behavior, 39(4):959-967.
Impact factor 2010: 3.66, Q1 in Social Sciences, Interdisciplinary
46. Inciardi, JA, Surratt, HL, Cicero, TJ, & Beard, RA. 2009. “Prescription Opioid Abuse and Diversion in an Urban Community: The Results of an Ultra- Rapid Assessment,” Pain Medicine, 10(3): 537-538. Impact factor 2009: 2.39, Q2 in Medicine, General & Internal
47. Havens, JR, Leukefeld, CG, Oser, CB, Staton-Tindall, M, Knudsen, HK, Mooney, J, Duvall, JL, Clarke, JG, Frisman, L, Surratt, HL, & Inciardi, JA. 2009. “Examination of an Interventionist-Led HIV Intervention among Criminal Justice-Involved Female Prisoners,” Journal of Experimental Criminology, 5(3): 245-272.
Impact factor 2013: 1.81, Q1 in Criminology & Penology
48. Robbins, C., Martin, S. and Surratt, H. 2009. “Substance Abuse Treatment, Anticipated Maternal Roles, and Reentry Success of Drug-Involved Women Prisoners,” Crime & Delinquency 55(3): 388-411.
Impact factor 2009: 1.54, Q2 in Criminology & Penology
49. Inciardi, JA, Surratt, HL, Cicero, TJ, Kurtz, SP, Martin, SS, & Parrino, MW. 2009. “The ‘Black Box’ of Prescription Drug Diversion,” Journal of Addictive Diseases, 28 (4):332-347.
Impact factor 2009: 1.23, Q2 in Substance Abuse
50. Martin, SS, O’Connell, DJ, Inciardi, JA, Surratt, HL, & Maiden, KM. 2008. “Integrating an HIV/HCV Brief Intervention in Prisoner Reentry: Results of a Multi-Site Prospective Study,” Journal of Psychoactive Drugs, 40: 427-436.
Impact factor 2008: 0.80, Q4 in Substance Abuse
51. Knudsen, HK, Leukefeld, CG, Havens, JR, Duvall, JL, Oser, CB, Staton-Tindall, M, Mooney, J, Clarke, JG, Frisman, L, Surratt, HL, & Inciardi, JA. 2008. “Partner Relationships and HIV Risk Behaviors among Women Offenders,” Journal of Psychoactive Drugs, 40: 471-481.
Impact factor 2008: 0.80, Q4 in Substance Abuse
52. Cicero, TJ, Lynskey, M, Todorov, A, Inciardi, JA, & Surratt, HL. 2008. “Comorbid Pain and Psychopathology in Males and Females Admitted to Treatment for Opioid Analgesic Abuse,” Pain, 139(1):127-135.
Impact factor 2008: 6.03, Q1 in Neurosciences
53. Surratt, HL. 2007. “Sex Work in the Caribbean Basin: Patterns of Substance Use and HIV Risk among Migrant Sex Workers in the United States Virgin Islands,” AIDS Care, 19(10):1274-1282.
Impact factor 2007: 1.84, Q1 in Social Sciences, Biomedical
54. Cicero, TJ, Inciardi, JA, & Surratt, HL. 2007. “Trends in the Use and Abuse of Branded and Generic Extended Release Oxycodone and Fentanyl Products in the United States,” Drug and Alcohol Dependence, 91(2-3):115-120.
Impact factor 2007: 3.22, Q1 in Substance Abuse
55. Saum, CA, Hiller, ML, Leigey, ME, Inciardi, JA, & Surratt, HL. 2007. “Predictors of Substance Abuse Treatment Entry for Crime-Involved Cocaine-Dependent Women,” Drug and Alcohol Dependence, 91(2-3):253-259.
Impact factor 2007: 3.22, Q1 in Substance Abuse
56. Cicero, TJ, Surratt, HL, Inciardi, JA, & Muñoz, A. 2007. Relationship Between Therapeutic Use and Abuse of Opioid Analgesics in Rural, Suburban, and Urban Locations in the United States,” Pharmacoepidemiology and Drug Safety, 16(8):827-840.
Impact Factor 2007: 2.48; Q2 in Pharmacology & Pharmacy
57. Pechansky, F, Bassani, D, Von Diemen, L, Kessler, F, Leukefeld, CG, Surratt, HL, Inciardi, JA, & Martin, SS. 2007. “Using Thought Mapping and Structured Stories to Decrease HIV Risk Behaviors among Cocaine Injectors and Crack Smokers in the South of Brazil,” Revista Brasileira de Psiquiatria, 29(3):233-240.
Impact Factor 2007: 1.23; Q3 in Psychiatry
58. Havens, JR, Oser, CB, Leukefeld , CG, Webster, JM, Martin, SS, O'Connell, DJ, Surratt, HL, & Inciardi, JA. 2007. “Differences in Prevalence of Prescription Opiate Misuse among Rural and Urban Probationers,” American Journal of Drug and Alcohol Abuse, 33:309-317.
Impact Factor 2007: 1.24; Q2 in Substance Abuse
59. Inciardi, JA, Surratt, HL, Martin, SS, O’Connell, DJ, Salandy, A, & Beard, RA. 2007. “Developing a Multimedia HIV and Hepatitis Intervention for Drug-Involved Offenders Reentering the Community,” The Prison Journal, 87: 111-142.
Impact Factor 2007: 0.36; Q3 in Criminology & Penology
60. Staton-Tindall, M., Leukefeld, CG, Palmer, J, Oser, JB, Kaplan, A, Krietemeyer, J, Saum, CA, & Surratt, HL. 2007. “Relationships and HIV Risk among Incarcerated Women,” The Prison Journal, 87:143-165.
Impact Factor 2007: 0.36; Q3 in Criminology & Penology
61. Pechansky, F, Kessler, F, Von Diemen, L, Benzano Bumaguin, D, Surratt, HL, & Inciardi, JA. 2007. “Brazilian Female Crack Users Show Elevated Serum Aluminum Levels,” Revista Brasileira de Psiquiatria, 29(1):39-42.
Impact Factor 2007: 1.239; Q3 in Psychiatry
62. Inciardi, JA, Surratt, HL, Kurtz, SP, & Cicero, TJ. 2007. “Mechanisms of Prescription Drug Diversion Among Drug Involved Club and Street Populations,” Pain Medicine, 8(2):171-183.
Impact Factor 2007: 2.74; Q1 in Medicine, General & Internal
63. Pechansky, F, Woody, G, Inciardi, JA, Surratt, HL, Kessler, F, Von Diemen, L, & Benzano Bumaguin, D. 2006. “HIV Seroprevalence Among Drug Users: An Analysis of Selected Variables Based on 10 Years of Data Collection in Porto Alegre, Brazil,” Drug and Alcohol Dependence, 82: S109-113.
Impact Factor 2006: 3.21; Q2 in Substance Abuse
64. Inciardi, JA, Surratt, HL, Pechansky, F, Kessler, F, Von Diemen, L, Meyer da Silva, E, & Martin, SS. 2006. “Changing Patterns of Cocaine Use and HIV Risks in the South of Brazil,” Journal of Psychoactive Drugs, 38(3):305-310.
Impact Factor 2006: 0.83; Q3 in Substance Abuse
65. Inciardi, JA, Surratt, HL, Kurtz, SP, & Burke, JJ. 2006. “The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio,” Substance Use and Misuse, 41:255-264.
Impact Factor 2006: 1.38; Q3 in Substance Abuse
66. Inciardi, JA, Surratt, HL, & Kurtz, SP. 2006. “HIV, HBV, HCV Infections among Drug-Involved Street Sex Workers in Miami, Florida,” AIDS and Behavior, 10:137-147.
Impact Factor 2006: 1.98; Q1 in Social Sciences, Biomedical
67. Surratt, HL, & Inciardi, JA. 2005. “Developing an HIV Intervention for Indigent Women Substance Abusers in the United States Virgin Islands,” Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82(3, Suppl. 4): iv74-iv83.
Impact Factor 2005: 2.49; Q1 in Public, Environmental, & Occupational Health
68. Pechansky, F, Kessler, F, Von Diemen, L, Inciardi, JA, & Surratt, HL. 2005. “Substance Use, Risk Situations, and HIV Seroprevalence among Individuals Seeking Free HIV Testing in Porto Alegre, Brasil,” Journal of the Pan American Health Organization, 18(4-5):249-255.
Impact Factor 2013: 0.72; Q4 in Public, Environmental, & Occupational Health
69. Kurtz, SP, Inciardi, JA, Surratt, HL, & Cottler, L. 2005. "Prescription Drug Abuse among Ecstasy Users in Miami," Journal of Addictive Diseases, 24:1-16.
Impact Factor 2005: 0.89; Q3 in Substance Abuse
70. Surratt, HL, Inciardi, JA, Weaver, JC, & Falú, VM. 2005. “Emerging Linkages Between Substance Abuse and HIV Infection in St. Croix, United States Virgin Islands,” AIDS Care, 17: S26-S35.
Impact Factor 2005: 1.64, Q1 in Psychology, multidisciplinary
71. Kurtz, SP, Surratt, HL, Kiley, MC, & Inciardi, JA. 2005. “Barriers to Health and Social Services for Street-Based Sex Workers,” Journal of Health Care for the Poor and Underserved, 16:345-361. Impact Factor 2005: 0.82, Q3 in Public, Environmental, & Occupational Health
72. Inciardi, JA, Surratt, HL, Kurtz, SP, & Weaver, JC. 2005. “The Effect of Serostatus on HIV Risk Behaviour Change Among Women Sex Workers in Miami, Florida,” AIDS Care, 17: S88-S101. Impact Factor 2005: 1.64, Q1 in Psychology, multidisciplinary
73. Leukefeld, CG, Pechansky, F, Martin, SS, Surratt, HL, Inciardi, JA, Kessler, F, Orsi, MM, Von Diemen, L, & Meyer da Silva, E. 2005. “Tailoring an HIV Prevention Intervention for Cocaine Injectors and Crack Users in Porto Alegre, Brazil,” AIDS Care, 17:S77-S87.
Impact Factor 2005: 1.64, Q1 in Psychology, multidisciplinary
74. Surratt, HL & Inciardi, JA. 2004. “HIV Risk, Seropositivity and Predictors of Infection among Homeless and Non-Homeless Women Sex Workers in Miami, Florida, USA,” AIDS Care, 16: 594-604. Impact Factor 2004: 1.56, Q1 in Psychology, multidisciplinary
75. Inciardi, JA, Surratt, HL, Martin, SS, & Gealt, R. 2004. “Prevalence of Narcotic Analgesic Abuse Among Students: Individual or Polydrug Abuse?” Archives of Pediatric and Adolescent Medicine, 158: 498-499.
Impact Factor 2004: 2.89, Q1 in Pediatrics
76. Surratt, HL, Inciardi, JA, Kurtz, SP, & Kiley, MC. 2004. “Sex Work and Drug Use in a Subculture of Violence,” Crime & Delinquency, 50: 43-59.
Impact Factor 2004: 1.19, Q2 in Criminology & Penology
77. Kurtz, SP, Surratt, HL, & Inciardi, JA. 2004. “Sex Work and “Date” Violence,” Violence Against Women, 10:357-385.
Impact Factor 2004: 1.11, Q1 in Women’s Studies
78. Martin, SS, O’Connell, DJ, Inciardi, JA, Surratt, HL, & Beard, RA. 2003. “HIV/AIDS among Probationers: An Assessment of Risk and Results from a Brief Intervention,” Journal of Psychoactive Drugs, 35: 435-443.
Impact Factor 2003: 0.85; Q3 in Substance Abuse
79. Surratt, HL. 2003. “Parenting Attitudes of Drug-Involved Women Inmates,” Prison Journal, 83: 206-220.
Impact Factor 2003: 0.98; Q3 in Criminology & Penology
80. 69. Inciardi, JA, & Surratt, HL. 2001. “Cross Cultural Approaches to Harm Reduction Research: Some Considerations on the Brazil Experience,” Substance Use and Misuse, 36:201-212.
Impact Factor 2009: 0.98
81. Leukefeld, CG, Farabee, D, McDermeit, M, Dennis, M, Wechsberg, WM, Inciardi, JA, Surratt, HL, Compton, WM, Cottler, LB, Klein, H, Hoffman, JA, Desmond, D, & Logan, TK. 2001. “Real and Perceived HIV Risk by Population Density: An Exploratory Examination,” Journal of Drug Issues, 31(4):889-900.
Impact Factor 2001: 0.75
82. Inciardi, JA, & Surratt, HL. 2001. “Drug Use, Street Crime, and Sex Trading among Cocaine-Dependent Women: Implications for Public Health and Criminal Justice Policy,” Journal of Psychoactive Drugs, 33(4):379-389.
Impact Factor 2001: 0.56
83. Surratt, HL. 2000. “Indigence, Marginalization and HIV Infection among Brazilian Cocaine Users” Drug and Alcohol Dependence 58:267-274.
Impact Factor 2000: 2.69
84. Surratt, HL, & Inciardi, JA. 1999. "Introducing the Female Condom to Drug Users in Brazil" Population Research and Policy Review 18(1-2): 169-181.
Impact Factor 1999: 0.05
85. Inciardi, JA, Surratt, HL, Colon, H, Chitwood, DD, & Rivers, JE. 1999. "Drug Use and HIV Risks Among Migrant Workers on the DelMarVa Peninsula," Substance Use and Misuse 34(4-5):653-666.
Impact Factor 1999: 0.54
86. Surratt, HL, Wechsberg, WM, Cottler, LB, Leukefeld, CG, Klein, H, & Desmond, D. 1998. "Acceptability of the Female Condom among Women at Risk for HIV Infection," American Behavioral Scientist 41(8):1157-1170.
Impact Factor 1998: 0.67
87. McBride, DC, Inciardi, JA, Surratt, HL, Terry, Y, & VanBuren, H. 1998. "The Impact of an HIV Risk Reduction Program among Street Drug Users in Rio de Janeiro, Brazil," American Behavioral Scientist 41(8):1171-1184.
Impact Factor 1998: 0.67
88. Surratt, HL, & Inciardi, JA. 1998. “Unraveling the Concept of Race in Brazil: Issues for the Rio de Janeiro Cooperative Agreement Site,” Journal of Psychoactive Drugs, 30: 255-260.
Impact Factor 1998: 0.49
89. Inciardi, JA, & Surratt, HL. 1998. "Children in the Streets of Brazil: Drug Use, Crime, Violence, and HIV Risks," Substance Use and Misuse 33: 1461-1480.
Impact Factor 1998: 0.46
90. Telles, PR, Bastos, FI, Guydish, J, Inciardi, JA, Surratt, HL, Pearl, M, 7 Hearst, N. 1997. "Risk Behavior and HIV Seroprevalence among IDUs in Rio de Janeiro, Brazil," AIDS, 11:S35-S42.
Impact Factor 2013: 6.56
91. Inciardi, JA, Surratt, HL, & McCoy, HV. 1997. "Establishing an HIV/AIDS Intervention Program for Street Drug Users in a Developing Nation," Journal of Drug Issues, 27:173-193.
Impact Factor 1998: 0.99
92. Inciardi, JA, and Surratt, HL. 1997. “Male Transvestite Sex Workers and HIV in Rio de Janeiro, Brazil," Journal of Drug Issues, 27:135-146.
Impact Factor 1998: 0.99
93. Mello, CO, Pechansky, F, Inciardi, JA, & Surratt, HL. 1997. "A Participant Observation of the Therapeutic Community as a Model for Drug Dependence Treatment," Journal of Drug Issues, 27: 299-314.
Impact Factor 1998: 0.99
94. Pottieger, AE, Tressell, P, Surratt, HL, Inciardi, JA, & Chitwood, DD. 1995. "Drug Use Patterns of Adult Crack Users in Street Versus Residential Treatment Samples," Journal of Psychoactive Drugs, 27: 27-38.
Impact Factor 1998: 0.49
95. Sridhar, KS, Raub, WA, Weatherby, NL, Metsch, LR, Surratt, HL, Inciardi, JA, Duncan, RC, Anwyl, RS, & McCoy, CB. 1994. "Possible Role of Marijuana Smoking as a Carcinogen in the Development of Lung Cancer at a Young Age," Journal of Psychoactive Drugs, 26: 285-288.
Impact Factor 1998: 0.49
A2. Articles with International Peer Review (not included in A1)
1. Buttram, ME, Surratt, HL, & Kurtz, SP. 2014. “Risk and Protective Factors Associated with Personal Mastery among Sexual Minority African American Female Sex Workers,” Journal of Gay & Lesbian Social Services.
2. Dart, RC, Cicero, TJ, Surratt, HL, Rosenblum, A, Bucher Bartelson, B, & Adams, EH. 2012. “Assessment of the abuse of tapentadol immediate release: The first 24 months.” Journal of Opioid Management 8(6):395-402.
3. Surratt, HL, & Inciardi, JA. 2010. “An Effective HIV Risk Reduction Protocol for Drug-Involved Women Sex Workers,” Journal of Prevention and Intervention in the Community, 38(2):118-131.
4. Cicero, TJ, Inciardi, JA, Surratt, HL, Horbay, GLA, Bordman, J, & Forster, I. 2010. “Characteristics of Precription Opioid Abuse in the United States and Canada,” Canadian Journal of Addiction Medicine, 1:9-13.
5. Inciardi, JA, Surratt, HL, Stivers, Y, & Cicero, TJ. 2009. “FDA Approvals of Generic Drugs: Impact on the Diversion of Opioid Analgesics with a Potential for Abuse,” Journal of Opioid Management, 5: 81-87.
6. Cicero, TJ, Surratt, HL, & Inciardi, JA. 2007. “Use and Misuse of Buprenorphine in the Management of Opioid Addiction,” Journal of Opioid Management, 3: 302-308.
7. Surratt, HL, Inciardi, JA, & Kurtz, SP. 2006. “Prescription Opioid Abuse Among Drug-Involved Street Sex Workers,” Journal of Opioid Management, 2(5):283-289.
8. Surratt, HL, Kurtz, SP, Weaver, JC, & Inciardi, JA. 2005. “The Connections of Mental Health Problems, Violent Life Experiences, and the Social Milieu of the ‘Stroll’ with the HIV Risk Behaviors of Female Street Sex Workers,” Journal of Psychology and Human Sexuality, 17:23-44.
9. Pechansky, F, Inciardi, JA, Surratt, HL, Lima, A, Kessler, F, Soibelman, M, & Hirakata, V. 2000. “Estudo sobre as characterísticas de usuários de drogas injetáveis que buscam atendimento em Porto Alegre, RS (A Study on the Characteristics of Intravenous Drug Users Who Seek Treatment in the City of Porto Alegre, Brazil),” Revista Brasileira de Psiquiatria, 22(4):164-171. (journal without impact factor at that time)
10. Inciardi, JA, Surratt, HL, Telles, PR, & Pok, BH. 1999. “Sex, Drugs, and the Culture of Travestismo in Rio de Janeiro,” International Journal of Transgenderism, 3:1-10.
11. Surratt, HL, &Inciardi, JA. 1998. "Drug Use and Risk for HIV/AIDS Among Indigent Women in Rio de Janeiro, Brazil" Drugs and Society 13:1-12.
12. Telles, PR, Inciardi, JA, Surratt, HL, Ferreira de Melo, R, & Baby, J. 1996. "Comportamentos de Risco para o HIV entre Travestis no Rio de Janeiro," Brazilian Journal of Medicine, 71:151-163.
13. Inciardi, JA, & Surratt, HL. 1996. "Les Communautes Therapeutiques en Carceral," Criminologie, XXIX (Spring):71-83.
14. Saum, CA, Surratt, HL, Inciardi, JA, & Bennett, RE. 1995. "Sex in Prison: Exploring the Myths and Realities," Prison Journal, 75:413-430. (journal without impact factor at that time)
15. Inciardi, JA, McBride, DC, McCoy, CB, Surratt, HL, & Saum, CA. 1995. "Violence, Street Crime, and the Drug Legalization Debate: A Perspective and Commentary on the U.S. Experience," Studies on Crime and Crime Prevention, 4: 105-118.
A3. Articles in National Journals (Not included in A1 or A2)
1. Inciardi, JA, Surratt, HL, Lugo, Y, & Cicero, TJ. 2007. “The Diversion of Prescription Opioid Analgesics,” Law Enforcement Executive Forum, 7(7):127-141.
2. Surratt, HL. 2007. “Risk and Protective Factors for Recidivism among Drug-Involved Female Offenders,” Law Enforcement Executive Forum, 7:157-168.
3. Surratt, HL. 2006. “Mental Health Problems and Criminal Justice Involvement Among Female Street-Based Sex Workers,” Law Enforcement Executive Forum, 6:121-134.
4. Surratt, HL, Telles, PR, & Inciardi, JA. 1999. “O Uso do Preservativo Feminino entre Usuarias de Drogas no Rio de Janeiro,” Revista da ABEAD 1:9-19.
5. Mello, CO, Pechansky, F, Inciardi, JA, & Surratt, HL. 1999. “A Comunidade Terapêutica como Modalidade de Tratamento para Dependentes Químicos: Relato de uma Observação Participante,” Revista HCPA 19:91-107.
6. Inciardi, JA, Surratt, HL, & Ferreira de Melo, R. 1997. "O Preservativo Feminino," Revista Brasilera de Medicina, 8:38-40.
B1. Books as Author
1. Inciardi, JA, Surratt, HL, & Telles, PR. 2000. Sex, Drugs and HIV/AIDS in Brazil. Boulder, CO: Westview Press.
2. Inciardi, JA, Surratt, HL, & Saum, CA. 1997. Cocaine-Exposed Infants. Thousand Oaks, CA: Sage Publications.
B2. Chapters in Books
1. O’Connell, DJ, Swan, H, Martin, SS, Surratt, HL, Visher, CA, Leukefeld, CG, Taxman, FS, & Rhodes, A. 2012. “A Continuum of Care Model for HIV in Correctional Settings,” pp. 255-271 in Sanders, B., Y. Thomas, and B. Deeds (eds), Crime, HIV and Health: Intersections of Criminal Justice and Public Health Concerns. Springer: New York.
2. Surratt, HL. 2008. “Gender-Specific Issues in the Treatment of Drug-Involved Women,” pp. 410-420 in Inciardi, JA & McElrath, K (eds.), The American Drug Scene V. New York: Oxford University Press.
3. Inciardi, JA, Surratt, HL, & Kurtz, SP. 2008. “African Americans, Crack, and the Federal Sentencing Guidelines,” pp. 214-224 in Inciardi, JA & McElrath, K (eds.), The American Drug Scene V. New York: Oxford University Press.
4. Kurtz, SP, Surratt, HL, Inciardi, JA, & Kiley, MC. 2006. “Violent Victimization of Street Sex Workers,” pp. 149-158 in L. Fiftal Alarid and P.Cromwell (eds.), In Her Own Words: Women Offenders’ Views on Crime and Victimization. Los Angeles: Roxbury Publishing Co.
5. Inciardi, JA, Surratt, HL, & Goode, JL. 2003. “Children in the Streets of Brazil: Drug Use, Crime, Violence, and HIV Risks,” in A. Melis (ed.), Periferie Dell’impero: Poteri Globali e Controllo Sociale. Rome: Derive Approdi.
6. Inciardi, JA, & Surratt, HL. 2002. “An HIV/AIDS Risk Reduction Model for Young Cocaine Users in Brazil,” pp 97-110 in F. E. Balcazar, M. Montero, and J.R. Neubrough (eds.), Health Promotion in the Americas: Theory and Practice. Washington, DC: Pan American Health Organization.
7. Inciardi, JA, Surratt, HL, Martin, SS, & Hooper, RM. 2002. “The Importance of Aftercare in a Corrections-Based Treatment Continuum,” pp. 204-216 in C. Leukefeld, F. Tims, & D. Farabee (eds.), Clinical and Policy Responses to Drug Offenders. New York: Springer Publishing Company.
8. Telles, PR, Bastos, FI, Inciardi, JA, & Surratt, HL. 2001. “Uma Década de Pesquisas sobre Usuários de Drogas Injetáveis & HIV/AIDS No Rio de Janeiro,” pp. 79-93 in A Contribuição dos Estudos Multicêntricos frente à Epidemia de HIV/AIDS entre UDI no Brasil : 10 Anos de Pesquisa e Redução de Danos. Brasília, Brazil : Ministry of Health.
9. Inciardi, JA, Martin, SS, & Surratt, HL. 2001. “Therapeutic Communities in Prisons and Work Release: Effective Modalities for Drug-Involved Offenders,” pp. 241-256 in B. Rawlings & R. Yates (eds.), Therapeutic Communities for the Treatment of Drug Users. London: Jessica Kingsley Publishers.
10. Surratt, HL, & Telles, PR. 2000. "Harm Reduction in Brazil: Issues and Experiences," pp. 137-153 in J.A. Inciardi & L.D. Harrison (eds.), Harm Reduction: National and International Perspectives. Thousand Oaks, CA: Sage Publications.
11. Surratt, HL. 1999. “Maternal Prenatal Violence” pp.335-336 in R. Gottesman & R. Brown (eds.) Violence in America. New York, NY: Charles Scribner’s Sons.
12. Surratt, HL, & Inciardi, JA. 1998. "Cocaine, Crack, and the Criminalization of Pregnancy," pp. 181-190 in J.A. Inciardi & K. McElrath (eds.), The American Drug Scene II. Los Angeles: Roxbury Publishing Co.
13. Inciardi, JA, & Surratt, HL. 1998. "African Americans, Crack, and Crime," pp. 170-180 in J.A. Inciardi & K. McElrath (eds.), The American Drug Scene II. Los Angeles: Roxbury Publishing Co
14. Inciardi, JA, McBride, DC, & Surratt, HL. 1998. “The Heroin Street Addict: Profiling a National Population,” pp.31-50 in J.A. Inciardi & L.D. Harrison (eds.) Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage Publications.
15. Lockwood, D, Inciardi, JA, & Surratt, HL. 1997. "CREST Outreach Center: A Model for Blending Treatment and Corrections," pp. 70-82 in J.A. Inciardi, B.W. Fletcher, P. Delany, & A.M. Horton (eds.), The Effectiveness of Innovative Approaches in the Treatment of Drug Abuse. Westport, CT: Greenwood Press.
16. Wechsberg, WM, MacDonald, B, Inciardi, JA, Surratt, HL, Leukefeld, CG, Farabee, D, Cottler, LB, Compton, W, Hoffman, J, Desmond, D, & Zule, WA. 1997. The NIDA Cooperative Agreement Standard Intervention: Protocol Changes Suggested by the Continuing HIV/AIDS Epidemic. Bloomington, IL: Lighthouse Institute.
17. Surratt, HL, & Inciardi, JA. 1996. "Drug Use, HIV Risks, and Prevention/Intervention Strategies Among Street Youths in Rio de Janeiro, Brazil," pp. 173-190 in C.B. McCoy, L.R. Metsch, & J.A. Inciardi (eds.) Intervening with Drug-Involved Youth. Thousand Oaks, CA: Sage Publications.
18. Inciardi, JA, Pottieger, AE, & Surratt, HL. 1996. "African-Americans and the Crack/Crime Connection," pp. 56-70 in D.D. Chitwood, J.E. Rivers, & J.A. Inciardi, The American Pipe Dream: Crack and the Inner City. Fort Worth, TX: Harcourt Brace.
19. 19. Inciardi, JA, Surratt, HL, & Chitwood, DD. 1996. "The Origins of Crack," pp. 1-14 in D.D. Chitwood, J.E. Rivers, & J.A. Inciardi, The American Pipe Dream: Crack and the Inner City. Fort Worth, TX: Harcourt Brace.
B3. Books as Editor: None
P1. Conference Proceedings in WOS: None
C1. Conference Proceedings not included in P1
1. Surratt, Hilary L. and James A. Inciardi, “Drug Use and HIV/AIDS in St. Croix, USVI,” Proceedings of the NIDA Satellite Meeting of the XIV International AIDS Conference, Youth Drug Abuse and HIV Infection in Cultural Context (Rockville: National Institute on Drug Abuse, 2003), pp. 123-129.